Drug delivery via the buccal mucosa

Pharmaceutical Science and Technology Today

Volumn 1, Issue 7, 1998, Pages 309-316

  Hoogstraate, Janet A J ^a   Wertz, Philip W ^a,b  

^a Biopharmaceutics   (Sweden)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATIPAMEZOLE; BUPRENORPHINE; CLONAZEPAM; ERGOTAMINE; ERGOTAMINE TARTRATE; ERYTHRITYL TETRANITRATE; FENTANYL; GLYCERYL TRINITRATE; HEPARIN; INSULIN; ISOSORBIDE 5 NITRATE; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; LEUPRORELIN; LORAZEPAM; METHYLTESTOSTERONE; MORPHINE SULFATE; NICOTINE; NICOTINE GUM; OCTREOTIDE; PHENTOLAMINE; PROTIRELIN RECEPTOR; TESTOSTERONE;

CHEEK MUCOSA; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; HUMAN; HUMAN TISSUE; MOUTH INFLAMMATION; MOUTH MUCOSA; MUCOSA CELL; ORAL DRUG ADMINISTRATION; REVIEW; SUBLINGUAL DRUG ADMINISTRATION;

EID: 0031671638     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(98)00076-5     Document Type: Review

References (55)

1. Lee V.H.L. Crit. Rev. Ther. Drug Deliv. Syst. 5:1988;69-97.
2. Merkle H.P., Wolany G. J. Control. Release. 21:1992;155-164.
3. Rathbone J., Hadgraft J. Int. J. Pharm. 74:1991;9-24.
4. Schroeder, H.E. (1981) Differentiation of Human Oral Stratified Epithelia, pp. 77-92 and 256-257, Karger, Basel, Switzerland.
5. Chen, S-Y. and Squier, C.A. (1984) in The Structure and Function of Oral Mucosa (Meyer, J., Squier, C.A. and Gerson, S.J., eds), pp. 7-30, Pergamon Press.
6. Squier C.A. Crit. Rev. Oral Biol. Med. 2:1991;13-32.
7. Squier C.A., Cox P., Wertz P.W. J. Invest. Dermatol. 96:1991;123-126.
8. Wertz, P.W., Hoogstraate, A.J. and Squier, C.A. (1996) in Oral Mucosal Drug Delivery (Rathbone, M.J., ed.), pp. 27-49, Marcel Dekker, Inc., New York, NY, USA.
9. Law S.A.et al. Archs. Oral Biol. 40:1995;1085-1091.
10. Garza J.et al. J. Dent. Res. 77:1998;293.
11. Lesch C.A.et al. J. Dent. Res. 68:1989;1345-1349.
12. Wertz, P.W. and Squier, C.A. (1996) in Oral Mucosal Drug Delivery (Rathbone, M.J., ed.), pp 1-26, Marcel Dekker, Inc., New York, NY, USA.
13. Nagai T., Konishi R. J. Control. Release. 6:1987;353-360.
14. DeGrande, G. et al. (1996) in Oral Mucosal Drug Delivery (Rathbone, M.J., ed.), pp. 285-317, Marcel Dekker, Inc., New York, NY, USA.
15. Gutniak M.K.et al. Diabetes Care. 20:1997;1874-1879.
16. Gutniak M.K.et al. Diabetes Care. 19:1996;843-848.
17. Anders R., Merkle H.P. Int. J. Pharm. 49:1989;231-240.
18. Nagai T., Machida Y. Adv. Drug Deliv. Rev. 11:1993;179-191.
19. Hoogstraate A.J., Boddé H.E. Adv. Drug Deliv. Rev. 12:1993;99-125.
20. Beckett A.H., Triggs E.R. J. Pharm. Pharmacol. 19:1967;31S-41S.
21. Dowty M.E.et al. Proc. Intern. Symp. Control. Release Bioact. Mater. 18:1990;226-227.
22. Aungst B.J., Rogers N.J. Int. J. Pharm. 53:1989;227-235.
23. Ishida M.et al. Chem. Pharm. Bull. 28:1981;810-816.
24. Oh C.K., Ritschel W.A. Methods Find. Exp. Clin. Pharmacol. 12:1990;205-212.
25. al-Achi A., Greenwood R. Res. Commun. Chem. Pathol. Pharmacol. 82:1993;297-306.
26. Steward A., Bayley D.L., Howes C. Int. J. Pharm. 104:1994;145-149.
27. Nakada Y.et al. J. Pharmacobio-Dyn. 12:1989;736-743.
28. Zhang J.et al. Int. J. Pharm. 101:1994;15-22.
29. Ebert C.D.et al. J. Control. Release. 28:1994;37-44.
30. Lee Y., Chien Y.W. Pharm. Res. 11:1994;S300.
31. Cassidy J.P., Landzert N.M., Quadros E. J. Control. Release. 25:1993;21-29.
32. Hoogstraate A.J.et al. J. Pharm. Sci. 85:1996;457-460.
33. Hoogstraate A.J.et al. Pharm. Res. 13:1996;1233-1237.
34. Hansen L.B., Christrup L.L., Bundgaard H. Int. J. Pharm. 88:1992;237-242.
35. Lee V.H.L., Yamamoto A., Bhaskar U. Crit. Rev. Ther. Drug Carrier Syst. 8:1991;91-192.
36. Schurr W.et al. J. Endocrinol. Invest. 8:1985;41-44.
37. Anders R.et al. Pharm. Sci. 72:1983;1481-1483.
38. Kuhlman J.J. Jr.et al. J. Anal. Toxicol. 20:1996;369-378.
39. McQuinn R.L.et al. J. Control. Release. 34:1995;243-250.
40. Kim S.et al. Contraception. 52:1995;313-316.
41. Huupponen R.et al. Clin. Pharmacol. Ther. 58:1995;506-511.
42. Schols-Hendriks M.W.et al. Br. J. Clin. Pharmacol. 39:1995;449-451.
43. Schechter N.L.et al. Pediatrics. 95:1995;427-428.
44. Schechter N.L.et al. Pediatrics. 96:1995;544.
45. Anlar S.et al. Pharm. Res. 11:1994;231-236.
46. Zorgniotti A.W. Int. J. Impotence Res. 6:1994;37-41.
47. Osipova N.A.et al. Anesteziol. Reanimatol. 4:1994;53-57.
48. Save T.et al. J. Pharm. Pharmacol. 46:1994;192-195.
49. Shyu W.C.et al. Biopharm. Drug Dispos. 14:1993;371-379.
50. Cassidy J.et al. Pharm. Res. 10:1993;126-129.
51. Wirthlin M.R.et al. J. Periodontol. 68:1997;746-749.
52. Ollmar S.et al. Med. Prog. Technol. 21:1995;29-37.
53. Draize J.H., Woodard G., Calvery H.O. J. Pharmacol. Exp. Ther. 82:1944;377-390.
54. Schendel K.U.et al. Fortschr. Keiferorthopadie. 55:1994;28-35.
55. Yang W., Acosta D. Toxicol. Lett. 70:1994;309-318.